EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genome-scale metabolic modeling reveals specific vaginal Lactobacillus strains and their metabolites as key inhibitors of Candida albicans

Tianqi Hu, Ya Meng, Changying Zhao, Dashuang Sheng, Sijie Yang, Junhui Dai, Tiantian Wei, Yiming Zhang, Guoping Zhao, Yanan Liu iD, Qinghua Wang iD, Lei Zhang iD

Microbiology Spectrum · 2025

DOI: 10.1128/spectrum.02984-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2025. Verfasst von Tianqi Hu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Microbiome-X, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, China. Hauptthemen laut MEDLINE: Candida albicans, Vagina, Lactobacillus. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

As the predominant constituents of the vaginal microbiome in healthy women, Lactobacillus species are considered essential in maintaining a homeostatic vaginal microbiome. Specific Lactobacillus species can produce beneficial metabolites to support their persistence within the host environment and inhibit Candida albicans colonization. Due to the extensive diversity of Lactobacillus species and their metabolites, comprehensively investigating all possible interactions remains challenging. This study employed an integrative approach combining genome-scale metabolic modeling, metagenomic sequencing, and in vitro validation to explore Lactobacillus and C. albicans interactions. Pairwise simulations of 159 Lactobacillus strains with C. albicans revealed that most strains exhibit inhibitory effects, altering fungal amino acid and carbohydrate metabolism. Key inhibitory metabolites identified included formate, L-lactate, and L-malate. Metagenomic analysis of vaginal swabs from 20 vulvovaginal candidiasis (VVC) patients and 20 healthy women showed a correlation between Lactobacillus species abundance and reduced C. albicans colonization. In vitro experiments confirmed the inhibitory effects of these metabolites and the selected Lactobacillus strains on C. albicans growth, thereby validating our computational predictions. These findings provide insights into the metabolic interactions within the vaginal microbiome and pave the way for targeted microbial or metabolite-based therapeutic strategies to manage VVC. IMPORTANCE Vulvovaginal candidiasis is a prevalent fungal infection with significant implications for women’s health, caused primarily by Candida albicans . Although the protective role of a Lactobacillus -dominated vaginal microbiome is well established, the metabolic mechanisms underlying the interactions between Lactobacillus species and C. albicans remain inadequately understood. Specifically, the Lactobacillus species that effectively inhibit C. albicans and the metabolic pathways involved warrant further investigation. This study offers novel insights into the metabolic mechanisms underlying Lactobacillus antagonism against C. albicans . By identifying critical metabolic pathways and inhibitory metabolites, this study enhances our understanding of vaginal microbiome dynamics and host-microbe interactions. The findings suggest that key Lactobacillus strains and their metabolites could significantly reduce harmful levels of C. albicans , paving the way for future therapeutic strategies that leverage these microbial characteristics to promote vaginal health.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Candida albicansVaginaLactobacillusFemaleHumansCandidiasis, VulvovaginalMicrobiotaAntibiosisAdultMicrobial InteractionsMetagenomics

Stichwörter der Autor:innen

Candida albicansLactobacillusgenome-scale metabolic models (GEMs)metabolic interactionsvulvovaginal candidiasis

Autor:innen und Institutionen

  • Microbiome-X, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, China.
  • State Key Laboratory of Reproductive Medicine and Offspring Health, Center for Reproductive Medicine, Institute of Women, Children and Reproductive Health, Shandong University, Jinan, China.
  • State Key Laboratory of Microbial Technology, Shandong University, Qingdao, China.
  • Jinan Institute of Child Health Care, Children's Hospital Affiliated to Shandong University (Jinan Children's Hospital), Jinan, China.
  • School of Biological Science and Technology, University of Jinan, Jinan, China.

ORCID-Profile: Yanan Liu, Qinghua Wang, Lei Zhang

Zitieren

APA

Hu, T., Meng, Y., Zhao, C., Sheng, D., Yang, S., Dai, J., Wei, T., Zhang, Y., Zhao, G., Liu, Y., Wang, Q., & Zhang, L. (2025). Genome-scale metabolic modeling reveals specific vaginal Lactobacillus strains and their metabolites as key inhibitors of Candida albicans. Microbiology Spectrum. https://doi.org/10.1128/spectrum.02984-24

Vancouver

Hu T, Meng Y, Zhao C, Sheng D, Yang S, Dai J, et al. Genome-scale metabolic modeling reveals specific vaginal Lactobacillus strains and their metabolites as key inhibitors of Candida albicans. Microbiology Spectrum. 2025. doi:10.1128/spectrum.02984-24

BibTeX
@article{Hu2025,
  author = {Hu, Tianqi and Meng, Ya and Zhao, Changying and Sheng, Dashuang and Yang, Sijie and Dai, Junhui and Wei, Tiantian and Zhang, Yiming and Zhao, Guoping and Liu, Yanan and Wang, Qinghua and Zhang, Lei},
  title = {Genome-scale metabolic modeling reveals specific vaginal Lactobacillus strains and their metabolites as key inhibitors of Candida albicans},
  journal = {Microbiology Spectrum},
  year = {2025},
  doi = {10.1128/spectrum.02984-24}
}
Kostenlos starten →